Pricing and Reimbursement Pathways of New Orphan Drugs in South Korea: A Longitudinal Comparison

This study aimed to analyze four current pathways affecting the listing and post-listing prices of new orphan drugs (ODs) in South Korea. These mechanisms were: (1) essential OD, (2) pharmacoeconomic evaluation (PE) waiver OD, (3) weighted average price OD, and (4) PE OD. We analyzed the ratio of th...

Descripción completa

Detalles Bibliográficos
Autor principal: Lee, Jong Hyuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000795/
https://www.ncbi.nlm.nih.gov/pubmed/33800373
http://dx.doi.org/10.3390/healthcare9030296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000795/
https://www.ncbi.nlm.nih.gov/pubmed/33800373
http://dx.doi.org/10.3390/healthcare9030296

Ejemplares similares